share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/07/18 18:41

Moomoo AI 已提取核心信息

BeiGene announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22, 2024, succeeding Julia Wang. Rosenberg, 48, joins from Merck & Co., where he most recently served as Senior VP and Corporate Treasurer. He will receive a base salary of $620,000 with a 60% target bonus and equity awards valued at $5 million.Julia Wang, the current CFO, will resign effective July 19, 2024, and serve as Senior Advisor until August 31 to assist with the transition. Wang will receive severance benefits including 18 months of base salary ($930,000), target bonus, and accelerated vesting of certain equity awards.BeiGene CEO John V. Oyler highlighted the company's status as a top 15 global oncology innovator by revenue, with plans to have at least 10 new molecular entities this year. The company emphasized its continued focus on scaling its business and reinforcing global leadership in hematology while building franchises in other prevalent cancers.
BeiGene announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22, 2024, succeeding Julia Wang. Rosenberg, 48, joins from Merck & Co., where he most recently served as Senior VP and Corporate Treasurer. He will receive a base salary of $620,000 with a 60% target bonus and equity awards valued at $5 million.Julia Wang, the current CFO, will resign effective July 19, 2024, and serve as Senior Advisor until August 31 to assist with the transition. Wang will receive severance benefits including 18 months of base salary ($930,000), target bonus, and accelerated vesting of certain equity awards.BeiGene CEO John V. Oyler highlighted the company's status as a top 15 global oncology innovator by revenue, with plans to have at least 10 new molecular entities this year. The company emphasized its continued focus on scaling its business and reinforcing global leadership in hematology while building franchises in other prevalent cancers.
百济神州宣布任命亚伦·罗森伯格为首席财务官,任命于2024年7月22日生效,接替王Julia。现年48岁的罗森伯格此前在默沙东担任高级副总裁和公司财务主管。他的基本工资为620,000美元,目标奖金为60%,以及价值500万美元的股权奖励。现任首席财务官王Julia将在2024年7月19日辞职,并在8月31日之前担任高级顾问,协助过渡。王将获得包括18个月基本工资(930,000美元)、目标奖金和某些股权奖励的加速归属在内的离职福利。百济神州首席执行官约翰·V·奥伊勒强调,公司的营业收入在全球肿瘤创新者中排名前15,并计划在今年推出至少10种新分子实体。公司强调将继续专注于扩大其业务,并巩固在血液学领域的全球领导地位,同时在其他常见癌症中建立业务。
百济神州宣布任命亚伦·罗森伯格为首席财务官,任命于2024年7月22日生效,接替王Julia。现年48岁的罗森伯格此前在默沙东担任高级副总裁和公司财务主管。他的基本工资为620,000美元,目标奖金为60%,以及价值500万美元的股权奖励。现任首席财务官王Julia将在2024年7月19日辞职,并在8月31日之前担任高级顾问,协助过渡。王将获得包括18个月基本工资(930,000美元)、目标奖金和某些股权奖励的加速归属在内的离职福利。百济神州首席执行官约翰·V·奥伊勒强调,公司的营业收入在全球肿瘤创新者中排名前15,并计划在今年推出至少10种新分子实体。公司强调将继续专注于扩大其业务,并巩固在血液学领域的全球领导地位,同时在其他常见癌症中建立业务。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息